A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Clinical trial NCT00425282 · COMPLETED

Trial details

NCT number: NCT00425282
Sponsor: SK Life Science, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy Epilepsy, Focal Seizure Disorder Complex Partial Seizures Epilepsy, Complex Partial

Start date: 2006-11-01
Primary completion: 2007-10-01
Enrollment: 566

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.